Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 14/20 | 0.41 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.41 |
| ▸ | EDNRB | P24530 | 6/20 | 0.35 |
| ▸ | KAT7 | O95251 | 3/20 | 0.33 |
| ▸ | KAT6A | Q92794 | 3/20 | 0.33 |
| ▸ | KAT6B | Q8WYB5 | 1/20 | 0.31 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.31 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4424920 | 0.84 | EDNRA (0.47) | EDNRAAGTR1EDNRB | |
| SCHEMBL4421491 | 0.84 | EDNRA (0.47) | EDNRAAGTR1EDNRBKAT7KAT6A | |
| SCHEMBL4426254 | 0.80 | EDNRA (0.34) | EDNRAAGTR1EDNRB | |
| SCHEMBL30295907 | 0.77 | EDNRA (0.47) | EDNRAAGTR1EDNRBKAT7KAT6A | |
| SCHEMBL4424315 | 0.76 | EDNRA (0.55) | EDNRAAGTR1EDNRB | |
| SCHEMBL4424916 | 0.75 | EDNRA (0.52) | EDNRAAGTR1EDNRB | |
| SCHEMBL13574912 | 0.75 | EDNRA (0.41) | EDNRAAGTR1EDNRB | |
| SCHEMBL4563627 | 0.73 | EDNRA (0.51) | EDNRAAGTR1EDNRBKAT7KAT6A | |
| SCHEMBL4563629 | 0.73 | EDNRA (0.49) | EDNRAAGTR1EDNRB | |
| SCHEMBL13574911 | 0.71 | EDNRA (0.40) | EDNRAEDNRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009155448-A1 | BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS | LIGAND PHARMACEUTICALS INC. (US) | 2009-12-23 | — | — | WO | claimed |